Phenotypic Clustering of Patients With Newly Diagnosed Coronary Artery Disease Using Cardiovascular Magnetic Resonance and Coronary Computed Tomography Angiography

Background: Epidemiological characteristics and prognostic profiles of patients with newly diagnosed coronary artery disease (CAD) are heterogeneous. Therefore, providing individualized cardiovascular (CV) risk stratification and tailored prevention is crucial.Objective: Phenotypic unsupervised clus...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Théo Pezel, Thierry Unterseeh, Thomas Hovasse, Anouk Asselin, Thierry Lefèvre, Bernard Chevalier, Antoinette Neylon, Hakim Benamer, Stéphane Champagne, Francesca Sanguineti, Solenn Toupin, Philippe Garot, Jérôme Garot
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/a1bba726d9e0464ca6fab0b443f31d09
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a1bba726d9e0464ca6fab0b443f31d09
record_format dspace
spelling oai:doaj.org-article:a1bba726d9e0464ca6fab0b443f31d092021-11-18T06:49:29ZPhenotypic Clustering of Patients With Newly Diagnosed Coronary Artery Disease Using Cardiovascular Magnetic Resonance and Coronary Computed Tomography Angiography2297-055X10.3389/fcvm.2021.760120https://doaj.org/article/a1bba726d9e0464ca6fab0b443f31d092021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fcvm.2021.760120/fullhttps://doaj.org/toc/2297-055XBackground: Epidemiological characteristics and prognostic profiles of patients with newly diagnosed coronary artery disease (CAD) are heterogeneous. Therefore, providing individualized cardiovascular (CV) risk stratification and tailored prevention is crucial.Objective: Phenotypic unsupervised clustering integrating clinical, coronary computed tomography angiography (CCTA), and cardiac magnetic resonance (CMR) data were used to unveil pathophysiological differences between subgroups of patients with newly diagnosed CAD.Materials and Methods: Between 2008 and 2020, consecutive patients with newly diagnosed obstructive CAD on CCTA and further referred for vasodilator stress CMR were followed for the occurrence of major adverse cardiovascular events (MACE), defined by cardiovascular death or non-fatal myocardial infarction. For this exploratory work, a cluster analysis was performed on clinical, CCTA, and CMR variables, and associations between phenogroups and outcomes were assessed.Results: Among 2,210 patients who underwent both CCTA and CMR, 2,015 (46% men, mean 70 ± 12 years) completed follow-up [median 6.8 (IQR 5.9–9.2) years], in which 277 experienced a MACE (13.7%). Three mutually exclusive and clinically distinct phenogroups (PG) were identified based upon unsupervised hierarchical clustering of principal components: (PG1) CAD in elderly patients with few traditional risk factors; (PG2) women with metabolic syndrome, calcified plaques on CCTA, and preserved left ventricular ejection fraction (LVEF); (PG3) younger men smokers with proximal non-calcified plaques on CCTA, myocardial scar, and reduced LVEF. Using survival analysis, the occurrence of MACE, cardiovascular mortality, and all-cause mortality (all p < 0.001) differed among the three PG, in which PG3 had the worse prognosis. In each PG, inducible ischemia was associated with MACE [PG1, Hazards Ratio (HR) = 3.09, 95% CI, 1.70–5.62; PG2, HR = 3.62, 95% CI, 2.31–5.7; PG3, HR = 3.55, 95% CI, 2.3–5.49; all p < 0.001]. The study presented some key limitations that may impact generalizability.Conclusions: Cluster analysis of clinical, CCTA, and CMR variables identified three phenogroups of patients with newly diagnosed CAD that were associated with distinct clinical and prognostic profiles. Inducible ischemia assessed by stress CMR remained associated with the occurrence of MACE within each phenogroup. Whether automated unsupervised phenogrouping of CAD patients may improve clinical decision-making should be further explored in prospective studies.Théo PezelThéo PezelThierry UnterseehThierry UnterseehThomas HovasseThomas HovasseAnouk AsselinThierry LefèvreBernard ChevalierAntoinette NeylonHakim BenamerStéphane ChampagneStéphane ChampagneFrancesca SanguinetiFrancesca SanguinetiSolenn ToupinPhilippe GarotPhilippe GarotJérôme GarotFrontiers Media S.A.articleclusteringphenomappingstress cardiovascular magnetic resonance imagingcoronary computed tomographic angiogram (CCTA)outcomesischemiaDiseases of the circulatory (Cardiovascular) systemRC666-701ENFrontiers in Cardiovascular Medicine, Vol 8 (2021)
institution DOAJ
collection DOAJ
language EN
topic clustering
phenomapping
stress cardiovascular magnetic resonance imaging
coronary computed tomographic angiogram (CCTA)
outcomes
ischemia
Diseases of the circulatory (Cardiovascular) system
RC666-701
spellingShingle clustering
phenomapping
stress cardiovascular magnetic resonance imaging
coronary computed tomographic angiogram (CCTA)
outcomes
ischemia
Diseases of the circulatory (Cardiovascular) system
RC666-701
Théo Pezel
Théo Pezel
Thierry Unterseeh
Thierry Unterseeh
Thomas Hovasse
Thomas Hovasse
Anouk Asselin
Thierry Lefèvre
Bernard Chevalier
Antoinette Neylon
Hakim Benamer
Stéphane Champagne
Stéphane Champagne
Francesca Sanguineti
Francesca Sanguineti
Solenn Toupin
Philippe Garot
Philippe Garot
Jérôme Garot
Phenotypic Clustering of Patients With Newly Diagnosed Coronary Artery Disease Using Cardiovascular Magnetic Resonance and Coronary Computed Tomography Angiography
description Background: Epidemiological characteristics and prognostic profiles of patients with newly diagnosed coronary artery disease (CAD) are heterogeneous. Therefore, providing individualized cardiovascular (CV) risk stratification and tailored prevention is crucial.Objective: Phenotypic unsupervised clustering integrating clinical, coronary computed tomography angiography (CCTA), and cardiac magnetic resonance (CMR) data were used to unveil pathophysiological differences between subgroups of patients with newly diagnosed CAD.Materials and Methods: Between 2008 and 2020, consecutive patients with newly diagnosed obstructive CAD on CCTA and further referred for vasodilator stress CMR were followed for the occurrence of major adverse cardiovascular events (MACE), defined by cardiovascular death or non-fatal myocardial infarction. For this exploratory work, a cluster analysis was performed on clinical, CCTA, and CMR variables, and associations between phenogroups and outcomes were assessed.Results: Among 2,210 patients who underwent both CCTA and CMR, 2,015 (46% men, mean 70 ± 12 years) completed follow-up [median 6.8 (IQR 5.9–9.2) years], in which 277 experienced a MACE (13.7%). Three mutually exclusive and clinically distinct phenogroups (PG) were identified based upon unsupervised hierarchical clustering of principal components: (PG1) CAD in elderly patients with few traditional risk factors; (PG2) women with metabolic syndrome, calcified plaques on CCTA, and preserved left ventricular ejection fraction (LVEF); (PG3) younger men smokers with proximal non-calcified plaques on CCTA, myocardial scar, and reduced LVEF. Using survival analysis, the occurrence of MACE, cardiovascular mortality, and all-cause mortality (all p < 0.001) differed among the three PG, in which PG3 had the worse prognosis. In each PG, inducible ischemia was associated with MACE [PG1, Hazards Ratio (HR) = 3.09, 95% CI, 1.70–5.62; PG2, HR = 3.62, 95% CI, 2.31–5.7; PG3, HR = 3.55, 95% CI, 2.3–5.49; all p < 0.001]. The study presented some key limitations that may impact generalizability.Conclusions: Cluster analysis of clinical, CCTA, and CMR variables identified three phenogroups of patients with newly diagnosed CAD that were associated with distinct clinical and prognostic profiles. Inducible ischemia assessed by stress CMR remained associated with the occurrence of MACE within each phenogroup. Whether automated unsupervised phenogrouping of CAD patients may improve clinical decision-making should be further explored in prospective studies.
format article
author Théo Pezel
Théo Pezel
Thierry Unterseeh
Thierry Unterseeh
Thomas Hovasse
Thomas Hovasse
Anouk Asselin
Thierry Lefèvre
Bernard Chevalier
Antoinette Neylon
Hakim Benamer
Stéphane Champagne
Stéphane Champagne
Francesca Sanguineti
Francesca Sanguineti
Solenn Toupin
Philippe Garot
Philippe Garot
Jérôme Garot
author_facet Théo Pezel
Théo Pezel
Thierry Unterseeh
Thierry Unterseeh
Thomas Hovasse
Thomas Hovasse
Anouk Asselin
Thierry Lefèvre
Bernard Chevalier
Antoinette Neylon
Hakim Benamer
Stéphane Champagne
Stéphane Champagne
Francesca Sanguineti
Francesca Sanguineti
Solenn Toupin
Philippe Garot
Philippe Garot
Jérôme Garot
author_sort Théo Pezel
title Phenotypic Clustering of Patients With Newly Diagnosed Coronary Artery Disease Using Cardiovascular Magnetic Resonance and Coronary Computed Tomography Angiography
title_short Phenotypic Clustering of Patients With Newly Diagnosed Coronary Artery Disease Using Cardiovascular Magnetic Resonance and Coronary Computed Tomography Angiography
title_full Phenotypic Clustering of Patients With Newly Diagnosed Coronary Artery Disease Using Cardiovascular Magnetic Resonance and Coronary Computed Tomography Angiography
title_fullStr Phenotypic Clustering of Patients With Newly Diagnosed Coronary Artery Disease Using Cardiovascular Magnetic Resonance and Coronary Computed Tomography Angiography
title_full_unstemmed Phenotypic Clustering of Patients With Newly Diagnosed Coronary Artery Disease Using Cardiovascular Magnetic Resonance and Coronary Computed Tomography Angiography
title_sort phenotypic clustering of patients with newly diagnosed coronary artery disease using cardiovascular magnetic resonance and coronary computed tomography angiography
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/a1bba726d9e0464ca6fab0b443f31d09
work_keys_str_mv AT theopezel phenotypicclusteringofpatientswithnewlydiagnosedcoronaryarterydiseaseusingcardiovascularmagneticresonanceandcoronarycomputedtomographyangiography
AT theopezel phenotypicclusteringofpatientswithnewlydiagnosedcoronaryarterydiseaseusingcardiovascularmagneticresonanceandcoronarycomputedtomographyangiography
AT thierryunterseeh phenotypicclusteringofpatientswithnewlydiagnosedcoronaryarterydiseaseusingcardiovascularmagneticresonanceandcoronarycomputedtomographyangiography
AT thierryunterseeh phenotypicclusteringofpatientswithnewlydiagnosedcoronaryarterydiseaseusingcardiovascularmagneticresonanceandcoronarycomputedtomographyangiography
AT thomashovasse phenotypicclusteringofpatientswithnewlydiagnosedcoronaryarterydiseaseusingcardiovascularmagneticresonanceandcoronarycomputedtomographyangiography
AT thomashovasse phenotypicclusteringofpatientswithnewlydiagnosedcoronaryarterydiseaseusingcardiovascularmagneticresonanceandcoronarycomputedtomographyangiography
AT anoukasselin phenotypicclusteringofpatientswithnewlydiagnosedcoronaryarterydiseaseusingcardiovascularmagneticresonanceandcoronarycomputedtomographyangiography
AT thierrylefevre phenotypicclusteringofpatientswithnewlydiagnosedcoronaryarterydiseaseusingcardiovascularmagneticresonanceandcoronarycomputedtomographyangiography
AT bernardchevalier phenotypicclusteringofpatientswithnewlydiagnosedcoronaryarterydiseaseusingcardiovascularmagneticresonanceandcoronarycomputedtomographyangiography
AT antoinetteneylon phenotypicclusteringofpatientswithnewlydiagnosedcoronaryarterydiseaseusingcardiovascularmagneticresonanceandcoronarycomputedtomographyangiography
AT hakimbenamer phenotypicclusteringofpatientswithnewlydiagnosedcoronaryarterydiseaseusingcardiovascularmagneticresonanceandcoronarycomputedtomographyangiography
AT stephanechampagne phenotypicclusteringofpatientswithnewlydiagnosedcoronaryarterydiseaseusingcardiovascularmagneticresonanceandcoronarycomputedtomographyangiography
AT stephanechampagne phenotypicclusteringofpatientswithnewlydiagnosedcoronaryarterydiseaseusingcardiovascularmagneticresonanceandcoronarycomputedtomographyangiography
AT francescasanguineti phenotypicclusteringofpatientswithnewlydiagnosedcoronaryarterydiseaseusingcardiovascularmagneticresonanceandcoronarycomputedtomographyangiography
AT francescasanguineti phenotypicclusteringofpatientswithnewlydiagnosedcoronaryarterydiseaseusingcardiovascularmagneticresonanceandcoronarycomputedtomographyangiography
AT solenntoupin phenotypicclusteringofpatientswithnewlydiagnosedcoronaryarterydiseaseusingcardiovascularmagneticresonanceandcoronarycomputedtomographyangiography
AT philippegarot phenotypicclusteringofpatientswithnewlydiagnosedcoronaryarterydiseaseusingcardiovascularmagneticresonanceandcoronarycomputedtomographyangiography
AT philippegarot phenotypicclusteringofpatientswithnewlydiagnosedcoronaryarterydiseaseusingcardiovascularmagneticresonanceandcoronarycomputedtomographyangiography
AT jeromegarot phenotypicclusteringofpatientswithnewlydiagnosedcoronaryarterydiseaseusingcardiovascularmagneticresonanceandcoronarycomputedtomographyangiography
_version_ 1718424370259427328